A Randomized Trial of Bevacizumab for Newly Diagnosed GlioblastomaMark R. Gilbert, Minesh P. Mehta, Kurt A. Jaeckle et al.|New England Journal of Medicine|2014Cited by 2.8k
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical TrialMark R. Gilbert, Minesh P. Mehta, Meihua Wang et al.|Journal of Clinical Oncology|2013Cited by 1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade GliomaJan C. Buckner, Walter J. Curran, Edward G. Shaw et al.|New England Journal of Medicine|2016Cited by 1k
Longitudinal molecular trajectories of diffuse glioma in adultsFloris P Barthel, Kerrie L. McDonald, Kevin C. Johnson et al.|Nature|2019Cited by 594
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastomaVerónica Rendo, Rameen Beroukhim, Eudocia Q. Lee et al.|Science Translational Medicine|2025Cited by 13